Two fat-soluble vitamins with a calcium-coordination partnership.
TL;DR: Vitamin D is one of the few supplements with official UK public-health guidance. D3 is the preferred form for raising blood levels. Vitamin K2 is biologically plausible as a calcium-directing partner, but large UK-specific outcome trials are limited. Neither vitamin has been proven to extend lifespan, but correcting deficiency may support bone, muscle and immune health in older adults.
Between October and March, the UK sun is too low for most skin types to make meaningful vitamin D. NHS surveys suggest that roughly 1 in 5 adults and up to 1 in 6 children have low vitamin D levels in winter. Older adults, people with darker skin, those who cover most of their skin, and people who are housebound or in care homes are at higher risk.
Vitamin D receptors are found in bone, muscle, immune cells, the cardiovascular system and the brain. Severe deficiency causes osteomalacia in adults; even mild insufficiency is linked to fractures, falls, respiratory infections and muscle weakness in older populations.
Vitamin D3 (cholecalciferol) is the form produced in skin. Most trials and meta-analyses find D3 raises and maintains serum 25-hydroxyvitamin D more effectively than D2 (ergocalciferol) at equivalent doses. D3 is therefore the default choice for supplementation in the UK.
Vitamin K2 (menaquinone) activates matrix Gla protein and osteocalcin. In simple terms, it helps calcium bind to bone and reduces calcium deposition in soft tissues such as arteries. The idea behind D3 + K2 stacks is that D3 increases calcium absorption while K2 ensures the calcium goes where it is needed.
The theory is supported by mechanistic and observational studies, and some smaller randomised trials suggest K2 improves bone mineral density and arterial stiffness markers. However, large UK trials showing that D3 + K2 together reduce fractures or cardiovascular events more than D3 alone are lacking.
| Situation | Typical daily dose | Notes |
|---|---|---|
| General adult maintenance (NHS) | 10 µg (400 IU) D3 in autumn/winter | All adults in UK autumn–winter; year-round for at-risk groups |
| Older adult / housebound | 25 µg (1,000 IU) D3 often used | Consider blood test to guide dose |
| Confirmed deficiency | Higher doses for 8–12 weeks, then maintenance | Should be guided by a clinician and blood test |
| K2 addition | MK-7 90–200 µg/day, or MK-4 45 mg/day in some protocols | Evidence for added cardiovascular benefit is not conclusive |
Vitamin D is fat-soluble and can accumulate. The NHS advises not exceeding 100 µg (4,000 IU) per day for adults without medical supervision. People with sarcoidosis, kidney disease, hyperparathyroidism or a history of kidney stones should speak to a clinician before supplementing.
Vitamin K2 interacts with warfarin and other vitamin-K antagonists. If you take anticoagulants, do not start K2 without medical advice.
💚 Check price on Amazon UK — vitamin D3 + K2
💚 Check price on Amazon UK — vitamin D3 1,000 IU
Affiliate ID placeholder: replace with Amazon Associates tag once configured.
These sources are referenced inline throughout the article and listed below for full transparency.
"Vitamin D and Health." Scientific Advisory Committee on Nutrition report recommending 10 µg/day for UK adults in autumn and winter.
View Report"Vitamin D supplementation to prevent acute respiratory tract infections." Individual participant data meta-analysis showing modest protective effect, especially in deficient people.
View DOI"Effect of vitamin D and omega-3 fatty acid supplementation on kidney function in older adults." DO-HEALTH substudy, also contextual for vitamin D safety in older populations.
View DOI"Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women." Landmark MK-7 bone-density trial.
View DOI"Effect of menaquinone-7 on progression of arterial stiffness in chronic kidney disease." Trial showing improved arterial stiffness with MK-7.
View DOIVitamin D helps calcium absorption, while vitamin K2 helps direct calcium to bones rather than arteries. The combination is biologically plausible, but large UK trials proving additive benefit of K2 on top of D3 are limited.
The NHS recommends 10 micrograms (400 IU) per day for most adults in autumn and winter. Higher doses may be used short term to correct deficiency, but should be guided by a blood test because vitamin D can accumulate.
Large meta-analyses of vitamin D trials have not consistently shown a reduction in all-cause mortality in the general population. Some studies suggest modest benefit in people who are deficient, but vitamin D is not proven to slow ageing.
MK-7 is the most studied form of K2 because it has a longer half-life than MK-4. MK-4 is also used, especially in Japan for bone health, but requires more frequent dosing.
This article may contain affiliate links to supplement products. If you purchase through these links, LongevityTortoise may earn a small commission at no extra cost to you. This does not influence our editorial judgements.
The content on this site is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional before starting any supplement, especially if you are pregnant, nursing, taking medication or have a medical condition. People on warfarin should not take vitamin K2 without medical advice.